Pages that link to "Q71795020"

The following pages link to Isomerization and formulation stability of the vaccine adjuvant QS-21 (Q71795020):

Displaying 28 items.

• Development of Improved Vaccine Adjuvants Based on the Saponin Natural Product QS-21 through Chemical Synthesis (Q28829361) (← links)
• Novel acetylated triterpenoid saponins in a chromatographic fraction from Quillaja saponaria Molina (Q30637859) (← links)
• Design and synthesis of potent Quillaja saponin vaccine adjuvants (Q33645835) (← links)
• Effective, nonsensitizing vaccination with culture filtrate proteins against virulent Mycobacterium bovis infections in mice. (Q33767136) (← links)
• Preclinical evaluation of the synthetic adjuvant SQS-21 and its constituent isomeric saponins (Q33899683) (← links)
• New advances in microsphere-based single-dose vaccines (Q33933148) (← links)
• Prevention of rotavirus infections in vitro with aqueous extracts of Quillaja Saponaria Molina (Q34065875) (← links)
• Characterization of in vivo anti-rotavirus activities of saponin extracts from Quillaja saponaria Molina (Q35019757) (← links)
• Design, synthesis, and immunologic evaluation of vaccine adjuvant conjugates based on QS-21 and tucaresol (Q35539051) (← links)
• Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer (Q36856279) (← links)
• Synthesis of QS-21-xylose: establishment of the immunopotentiating activity of synthetic QS-21 adjuvant with a melanoma vaccine (Q37014879) (← links)
• l-Pentoses in Biological and Medicinal Applications (Q37852679) (← links)
• Enhancing Immunogenicity of Cancer Vaccines: QS-21 as an Immune Adjuvant (Q38282887) (← links)
• Quillaja Saponin Variants with Central Glycosidic Linkage Modifications Exhibit Distinct Conformations and Adjuvant Activities (Q39236688) (← links)
• Development of a single-shot subunit vaccine for HIV-1. 5. programmable in vivo autoboost and long lasting neutralizing response (Q41643549) (← links)
• Versatile strategy for the divergent synthesis of linear oligosaccharide domain variants of Quillaja saponin vaccine adjuvants. (Q43178410) (← links)
• Synthetic studies of complex immunostimulants from Quillaja saponaria: synthesis of the potent clinical immunoadjuvant QS-21Aapi. (Q43211393) (← links)
• Altered immunomodulating and toxicological properties of degraded Quillaja saponaria Molina saponins. (Q43611516) (← links)
• Degradation of Quillaja saponaria Molina saponins: loss of the protective effects of a herpes simplex virus 1 subunit vaccine (Q45729917) (← links)
• Characterization of the MN gp120 HIV-1 vaccine: antigen binding to alum. (Q45974698) (← links)
• Relationship between haemolytic and adjuvant activity and structure of protopanaxadiol-type saponins from the roots of Panax notoginseng (Q46663461) (← links)
• Immunological adjuvant effect of Japanese ginseng saponins (JGS) on specific antibody and cellular response to ovalbumin and its haemolytic activities (Q50634543) (← links)
• Haemolytic activities and adjuvant effect of Astragalus membranaceus saponins (AMS) on the immune responses to ovalbumin in mice (Q50759965) (← links)
• Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis (Q57268157) (← links)
• Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity (Q73902433) (← links)
• Adjuvant effect of water-soluble polysaccharide (PAP) from the mycelium of Polyporus albicans on the immune responses to ovalbumin in mice (Q81459566) (← links)
• Atomic model and micelle dynamics of QS-21 saponin (Q87506519) (← links)
• Synthesis and Evaluation of QS-7-Based Vaccine Adjuvants (Q92669700) (← links)